Cargando…
Filgotinib in Rheumatoid Arthritis: A Profile of Its Use
Filgotinib (Jyseleca(®)), an oral Janus kinase (JAK) inhibitor, is approved as monotherapy or in combination with methotrexate to treat moderate to severe active rheumatoid arthritis (RA) in adults who have an inadequate response or intolerance to one or more disease-modifying antirheumatic drugs (D...
| Autores principales: | , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Springer International Publishing
2021
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8613087/ https://www.ncbi.nlm.nih.gov/pubmed/34304373 http://dx.doi.org/10.1007/s40261-021-01055-0 |